Rmr Wealth Builders Global Blood Therapeutics, Inc. Transaction History

Rmr Wealth Builders

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.46 - $43.42 $12,984 - $17,368	-400 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$38.94 - $50.85 $9,735 - $12,712	-250 Reduced 38.46%	400 $16,000
Q4 2020 Feb 26, 2021	BUY	$37.65 - $63.77 $24,472 - $41,450	650 New	650 $28,000
Q3 2020 Nov 13, 2020	SELL	$52.76 - $74.49 $15,828 - $22,347	-300 Closed	0 $0
Q4 2019 Mar 03, 2020	BUY	$45.7 - $81.86 $13,710 - $24,558	300 New	300 $24,000

288K

Ticker GBT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 67,476,200
Market Cap $4.62B
Description
Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses...

Get notified when there are updates to the investment portfolio of Rmr Wealth Builders, based on Form 13F filings with the SEC.

Stay updated on Rmr Wealth Builders with notifications on news.